First-choice treatment preferences for primary open-angle glaucoma in the United Kingdom [6]

Eye

Volumn 19, Issue 8, 2005, Pages 923-924

  McKee, Hamish D R ^a   Gupta, M S ^a   Ahad, M A ^a   Saldana M ^a   Innes, J R ^a  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; LATANOPROST; PROSTAGLANDIN DERIVATIVE; TOPICAL AGENT;

ARGON LASER; CLINICAL OBSERVATION; CONTROLLED STUDY; FILTERING OPERATION; HUMAN; LASER SURGERY; LETTER; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGY; QUESTIONNAIRE; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TRABECULECTOMY; TRABECULOPLASTY; TREATMENT PLANNING; UNITED KINGDOM; VISUAL FIELD DEFECT;

EID: 23944460063     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701674     Document Type: Letter

References (6)

1. Vernon S, Hugkulstone C, Jay J, Ménage M, Fielder A. Guidelines for the Management of Ocular Hypertension and Primary Open Angle Glaucoma. The Royal College of Ophthalmologists: London, 1997.
2. European Glaucoma Society. Terminology and Guidelines for Glaucoma, 2nd ed. Editrice DOGMA S.r.l.: Savona, 2003.
3. American Academy of Ophthalmology Preferred Practice Patterns Committee Glaucoma Panel. Preferred Practice Pattern: Primary Open-Angle Glaucoma. American Academy of Ophthalmology: San Francisco, CA, 2000.
4. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol 2003; 121: 957-960.
5. Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (Selective Laser Trabeculoplasty). A multicenter pilot clinical study. Ophthalmology 1998; 105: 2082-2090.
6. Parrish RK, Palmberg P, Sheu WP, XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003; 135: 688-703.